| Leticia De Carvalho Lopes, FNP | |
|
301 Yadkin St, Albemarle, NC 28001-3441 | |
| (704) 984-4365 | |
| Not Available |
| Full Name | Leticia De Carvalho Lopes |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 301 Yadkin St, Albemarle, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538530340 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 5008113 (North Carolina) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 5008113 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stanly Regional Medical Center | Albemarle, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Physicians Network Inc | 3375449655 | 1613 |
News Archive
Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays.
Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health.
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology
› Verified 4 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477878890 PECOS PAC ID: 3375449655 Enrollment ID: O20031219000455 |
News Archive
Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays.
Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health.
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology
› Verified 4 days ago
| Entity Name | St. Luke's Physician Network Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205088796 PECOS PAC ID: 8224190277 Enrollment ID: O20081229000465 |
News Archive
Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays.
Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health.
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology
› Verified 4 days ago
| Entity Name | Columbus Regional Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508001009 PECOS PAC ID: 6608924931 Enrollment ID: O20090424000511 |
News Archive
Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays.
Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health.
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology
› Verified 4 days ago
| Entity Name | Scotland Regional Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972829562 PECOS PAC ID: 2365573185 Enrollment ID: O20100623000242 |
News Archive
Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays.
Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health.
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leticia De Carvalho Lopes, FNP Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Leticia De Carvalho Lopes, FNP 301 Yadkin St, Albemarle, NC 28001-3441 Ph: (704) 984-4365 |
News Archive
Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays.
Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health.
Scientists from three UK universities have developed a new test to catch drugs-cheats in sport.
A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology
› Verified 4 days ago
Mrs. Phyllis T. Kupsick, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 313 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4388 Fax: 704-984-4132 | |
Kortney Wilson Clark, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 960 N 1st St, Albemarle, NC 28001 Phone: 704-983-4216 | |
Susan Lynn Russell Thomas, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 105 Yadkin St, Ste 303, Albemarle, NC 28001 Phone: 980-323-5400 | |
Clay Corpening Ijams, AGPCNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 24724 Us 52, Albemarle, NC 28001 Phone: 704-982-8191 | |
Katherine Dry Sells, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 105 Yadkin St, Ste 301, Albemarle, NC 28001 Phone: 980-323-5360 | |
Ruth L Silsby, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 105 Yadkin St, Ste 301, Albemarle, NC 28001 Phone: 980-323-5360 | |
Erin Elizabeth Perrotti, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 105 Yadkin St, Ste 301, Albemarle, NC 28001 Phone: 980-323-5360 |